IMMUNOSCAPE
LIVE

Serial Number

88035450

Owner

immunoscape Pte Ltd

Attorney

Jon Jekel

Filing Date

Jul 12, 2018

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNOSCAPE Trademark

Serial Number: 88035450 • Registration: 6039731

IMMUNOSCAPE is a trademark filed by immunoscape Pte Ltd on July 12, 2018. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

immunoscape Pte Ltd (5 trademarks)

1 Scotts Road
Singapore 228208 , SG

Entity Type: 99

Trademark Details

Filing Date

July 12, 2018

Registration Date

April 28, 2020

Published for Opposition

February 11, 2020

Goods & Services

Research and development services in the field of biotechnology; Research and development services in the field of immune profiling; research and development services in the field of immunotherapy; biotechnology services, namely, probing for multiple T cell specificities identification of tumor antigen-specific T cells for the treatment of cancer; biotechnology services, namely, probing for multiple T cell specificities identification of viral antigen-specific T cells in the field of infectious diseases; biotechnology services, namely, phenotypic and functional T cell and/or other immune cells profiling for use in the field of immunotherapy; biotechnology services, namely, analysis by time-of-flight mass cytometry; research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; biotechnology services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system; consulting services in the field of biotechnology through the application of mass cytometry; Research and development services in the field of vaccines; research and development of immunotherapy products; research and development of vaccines for use in the field of immunotherapy; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; biotechnology services, namely, analysis by flow cytometry; consulting services in the field of vaccine research and development in the field of immunotherapies; platform as a service (PAAS) featuring computer software platforms for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of online non-downloadable computer software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of online non-downloadable computer software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features; providing temporary use of on-line non-downloadable cloud computing software for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of on-line non-downloadable cloud computing software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of on-line non-downloadable cloud computing software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 28, 2025 REM1
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 3, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 3, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 3, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 3, 2024 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 6, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 6, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 6, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Apr 28, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 30, 2019 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 5, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 5, 2019 GNSL
SUSPENSION LETTER WRITTEN
Dec 5, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 3, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 22, 2019 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 20, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 20, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 20, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 19, 2019 RCCK
ASSIGNED TO LIE
Nov 12, 2019 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 19, 2019 TCCA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 18, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 18, 2019 GNSL
SUSPENSION LETTER WRITTEN
Apr 18, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2018 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2018 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2018 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2018 NWOS
NEW APPLICATION ENTERED
Jul 16, 2018 NWAP